- Home
- FLYW vs CLDX Comparison
FLYW vs CLDX Comparison
Compare FLYW & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYW
- CLDX
- Stock Information
- Founded
- FLYW 2009
- CLDX N/A
- Country
- FLYW United States
- CLDX United States
- Employees
- FLYW N/A
- CLDX N/A
- Industry
- FLYW Computer Software: Prepackaged Software
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- FLYW Technology
- CLDX Health Care
- Exchange
- FLYW Nasdaq
- CLDX Nasdaq
- Market Cap
- FLYW 1.1B
- CLDX 1.3B
- IPO Year
- FLYW 2021
- CLDX 2008
- Fundamental
- Price
- FLYW $10.99
- CLDX $18.48
- Analyst Decision
- FLYW Buy
- CLDX Buy
- Analyst Count
- FLYW 16
- CLDX 9
- Target Price
- FLYW $17.71
- CLDX $55.50
- AVG Volume (30 Days)
- FLYW 3.1M
- CLDX 702.8K
- Earning Date
- FLYW 05-06-2025
- CLDX 05-08-2025
- Dividend Yield
- FLYW N/A
- CLDX N/A
- EPS Growth
- FLYW N/A
- CLDX N/A
- EPS
- FLYW 0.04
- CLDX N/A
- Revenue
- FLYW $511,493,000.00
- CLDX $7,020,000.00
- Revenue This Year
- FLYW $13.82
- CLDX N/A
- Revenue Next Year
- FLYW $16.22
- CLDX N/A
- P/E Ratio
- FLYW $309.78
- CLDX N/A
- Revenue Growth
- FLYW 20.97
- CLDX 1.99
- 52 Week Low
- FLYW $8.20
- CLDX $14.40
- 52 Week High
- FLYW $23.40
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- FLYW 69.48
- CLDX 51.36
- Support Level
- FLYW $9.50
- CLDX $17.85
- Resistance Level
- FLYW $11.43
- CLDX $19.94
- Average True Range (ATR)
- FLYW 0.39
- CLDX 1.10
- MACD
- FLYW 0.35
- CLDX -0.01
- Stochastic Oscillator
- FLYW 86.85
- CLDX 45.58
About FLYW Flywire Corporation Voting
Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements namely a payments platform; a proprietary global payment network and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.